Adenosine receptor targeting in health and disease

Bibliography

• Colgan SP, Eltzschig HK, Eckle T, Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006;20:351-60
   Google Scholar
• Fredholm BB, IJzerman AP, Jacobson KA, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-52
   PubMed Web of Science ®Google Scholar
• Fredholm BB. Adenosine receptors as drug targets. Exp Cell Res 2010;316:1284-8
   PubMed Web of Science ®Google Scholar
• Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004;25:33-9
   PubMed Web of Science ®Google Scholar
• Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005;67:1385-7
   PubMed Web of Science ®Google Scholar
• Hasko G, Linden J, Cronstein B, Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008;7:759-70
   PubMed Web of Science ®Google Scholar
• Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-92
   PubMed Web of Science ®Google Scholar
• Van Calker DM, Muller M, Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 1979;33:999-1005
   PubMed Web of Science ®Google Scholar
• Jajoo S, Mukherjea D, Kumar S, Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery. Am J Physiol Cell Physiol 2010;298:C56-65
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Rivera-Nieves J, Colgan SP. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets 2009;13:1267-77
   PubMed Web of Science ®Google Scholar
• Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 2007;8:1-6
   Google Scholar
• Gong QJ, Li YY, Xin WJ, Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats. Brain Res 2010;1361:23-30
   PubMed Web of Science ®Google Scholar
• Nascimento FP, Figueredo SM, Marcon R, Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther 2010;334:590-8
   PubMed Web of Science ®Google Scholar
• Sowa NA, Street SE, Vihko P, Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci 2010;30:10282-93
   Google Scholar
• Gan TJ, Habib AS. Adenosine as a non-opioid analgesic in the perioperative setting. Anaesth Analg 2007;105:487-94
   PubMed Web of Science ®Google Scholar
• Schmidt AP, Bohmer AE, Antunes C, Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol 2009;156:163-72
   PubMed Web of Science ®Google Scholar
• Romagnoli R, Baraldi PG, Tabrizi MA, Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development. Curr Med Chem 2010;17:3488-502
   PubMed Web of Science ®Google Scholar
• Baraldi PG, Zaid AN, Lampronti I, Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorg Med Chem Lett 2000;10:1953-7
   PubMed Web of Science ®Google Scholar
• Baraldi PG, Romagnoli R, Pavani MG, Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. J Med Chem 2003;46:794-809
   PubMed Web of Science ®Google Scholar
• Russo C, Arcidiacono G, Polosa R. Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma. Fundam Clin Pharmacol 2006;20:9-19
   PubMed Web of Science ®Google Scholar
• Baraldi PG, Tabrizi MA, Gessi S, Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 2008;108:238-63
   PubMed Web of Science ®Google Scholar
• Driver AG, Kukoly CA, Ali S, Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993;148:91-7
   PubMed Web of Science ®Google Scholar
• Brown RA, Clarke GW, Ledbetter CL, Elevated expression of adenosine A1 receptor in bronchial biopsies from asthmatic subjects. Eur Respir J 2008;31:1-9
   Google Scholar
• Ponnoth DS, Nadeem A, Tilley S, Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol 2010;299:H81-7
   PubMed Web of Science ®Google Scholar
• Ethier MF, Madison JM. Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells. Am J Respir Cell Mol Biol 2006;35:496-502
   PubMed Web of Science ®Google Scholar
• Wilson CN. Adenosine receptors and asthma in humans. Br J Pharmacol 2008;155:475-86
   PubMed Web of Science ®Google Scholar
• Press NJ, Gessi S, Borea PA, Therapeutic potential of adenosine receptor antagonists and agonists. Expert Opin Ther Patent 2007;17:979-91
   PubMed Web of Science ®Google Scholar
• Sun CX, Young HW, Molina JG, A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 2005;115:35-43
   PubMed Web of Science ®Google Scholar
• Ngamsri KC, Wagner R, Vollmer I, Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol 2010;185:4374-84
   PubMed Web of Science ®Google Scholar
• Gazoni LM, Walters DM, Unger EB, Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2010;140:440-6
   PubMed Web of Science ®Google Scholar
• Koeppen M, Eckle T, Eltzschig HK. Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One 2009;4:e6784
   PubMedGoogle Scholar
• Schutte F, Burgdorf C, Richardt G, Adenosine A1 receptor-mediated inhibition of myocardial norepinephrine release involves neither phospholipase C nor protein kinase C but does involve adenylyl cyclase. Can J Physiol Pharmacol 2006;84:573-7
   PubMed Web of Science ®Google Scholar
• Shneyvays V, Leshem D, Zinman T, Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. Am J Physiol Heart Circ Physiol 2005;288:H2792-801
   PubMed Web of Science ®Google Scholar
• Solenkova NV, Solodushko V, Cohen MV, Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol 2006;290:H441-9
   PubMed Web of Science ®Google Scholar
• Yldiz G, Demiryurek AT, Gumusel B, Ischemic preconditioning modulates ischemia-reperfusion injury in the rat lung: role of adenosine receptors. Eur J Pharmacol 2007;556:144-50
   PubMed Web of Science ®Google Scholar
• Grenz A, Zhang H, Eckle T, Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 2007;18:833-45
   PubMed Web of Science ®Google Scholar
• Kiesman WF, Elzein E, Zablocki J. A1 adenosine receptor antagonists, agonists, and allosteric enhancers. In: Wilson CN, Mustafa SJ, editors. Adenosine receptors in health and disease, Handbook of Experimental Pharmacology. Springer-Verlag; Berlin Heidelberg: 2009. p. 25-58
   Google Scholar
• Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 2006;86:901-40
   PubMed Web of Science ®Google Scholar
• Zhou X, Kost CK. Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats. J Pharmacol Exp Ther 2006;316:530-8
   PubMed Web of Science ®Google Scholar
• Sun D, Samuelson LC, Yang T, Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 2001;98:9983-8
   PubMed Web of Science ®Google Scholar
• Schnermann J, Briggs JP. Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int 2008;74:418-26
   PubMed Web of Science ®Google Scholar
• Slawsky MT, Givertz MM. Rolofylline: a selective adenosine A1 receptor antagonist for the treatment of heart failure. Expert Opin Pharmacother 2009;10:311-22
   PubMed Web of Science ®Google Scholar
• Weatherley BD, Cotter G, Dittrich HC, PROTECT Steering Committee, Investigators, and Coordinators. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. J Cardiol Fail 2010;16:25-35
   PubMed Web of Science ®Google Scholar
• Voors AA, Dittrich HC, Massie BM, Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol 2011;57:1899-907
   PubMed Web of Science ®Google Scholar
• Hocher B. Adenosine A1 receptor antagonists in clinical research and development. Kidney Int 2010;78:438-45
   Web of Science ®Google Scholar
• Hocher B, Heiden S, von Websky K, Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLoS One 2011;10:e17891
   Google Scholar
• Pang PS, Mehra M, Maggioni AP, Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure. Am Heart J 2011;161:1012-23.e3
   PubMed Web of Science ®Google Scholar
• Kim M, Chen SW, Park SW, Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 2009;75:809-23
   PubMed Web of Science ®Google Scholar
• Chen SW, Park SW, Kim M, Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation 2009;87:1478-87
   PubMed Web of Science ®Google Scholar
• Kara FM, Chitu V, Sloane J, Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J 2010;24:2325-33
   PubMed Web of Science ®Google Scholar
• Kara FM, Doty SB, Boskey A, Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum 2010;62:534-41
   PubMed Web of Science ®Google Scholar
• Dhalla AK, Melissa S, Smith M, Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid. J Pharmacol Exp Ther 2007;321:327-33
   PubMed Web of Science ®Google Scholar
• Dhalla AK, Wong MY, Voshol PJ, A1-adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents. Am J Physiol Endocrinol Metab 2007;292:E1358-63
   PubMed Web of Science ®Google Scholar
• Fatholahi M, Xiang Y, Wu Y, A novel partial agonist of the A1-adenosine receptor and evidence of receptor homogeneity in adipocytes. J Pharmacol Exp Ther 2006;317:676-84
   PubMed Web of Science ®Google Scholar
• Shearer J, Severson DL, Su L, Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo. J Pharmacol Exp Ther 2009;328:306-11
   PubMed Web of Science ®Google Scholar
• Hasko G, Pacher P. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 2008;83:447-55
   PubMed Web of Science ®Google Scholar
• Sun CN, Cheng HC, Chou JL, Rescue of p53 blockage by the A2A adenosine receptor via a novel interacting protein, translin-associated protein X. Mol Pharmacol 2006;70:454-66
   PubMed Web of Science ®Google Scholar
• Lebon G, Warne T, Edwards PC, Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation. Nature 2011;474:521-5
   PubMed Web of Science ®Google Scholar
• Jenner P, Mori A, Hauser R, Adenosine, adenosine A2A antagonists, and Parkinson's disease. Parkinsonism Relat Disord 2009;15:406-13
   PubMed Web of Science ®Google Scholar
• Varani K, Bachoud-Levi AC, Mariotti C, Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiol Dis 2007;27:36-43
   PubMed Web of Science ®Google Scholar
• Simola N, Morelli M, Pinna A. Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions. Curr Pharm Des 2008;14:1475-89
   PubMed Web of Science ®Google Scholar
• LeWitt PA, Guttman M, Tetrud JW, Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 2008;63:295-302
   PubMed Web of Science ®Google Scholar
• Ramlackhansingh AF, Bose SK, Ahmed I, Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology 2011;76:1811-16
   PubMed Web of Science ®Google Scholar
• Varani K, Vincenzi F, Tosi A, A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. FASEB J 2010;24:587-98
   PubMed Web of Science ®Google Scholar
• Cavalcante JL, Barboza J, Ananthasubramaniam K. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients. J Nucl Cardiol 2011;18:628-33
   PubMed Web of Science ®Google Scholar
• Kern MJ, Hodgson JM, Dib N, Effects of apadenoson, a selective adenosine A2A receptor agonist for myocardial perfusion imaging, on coronary blood flow velocity in conscious patients. Circulation 2006;114: (Abstract)2780
   PubMedGoogle Scholar
• Bayes M. Gateways to clinical trials. Methods Find Exp Clin Pharmacol 2007;29:153-73
   PubMedGoogle Scholar
• Belardinelli L, Shryock JC, Snowdy S, The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 1998;284:1066-73
   PubMed Web of Science ®Google Scholar
• Varani K, Portaluppi F, Gessi S, Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 2000;102:285-9
   PubMed Web of Science ®Google Scholar
• Gessi S, Varani K, Merighi S, A2A adenosine receptors in human peripheral blood cells. Br J Pharmacol 2000;129:2-11
   PubMed Web of Science ®Google Scholar
• Blackburn MR, Vance CO, Morschl E, Adenosine receptors and inflammation. Handb Exp Pharmacol 2009;193:215-69
   PubMedGoogle Scholar
• Bingham TC, Fisher EA, Parathath S, A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. J Leukoc Biol 2010;87:683-90
   PubMed Web of Science ®Google Scholar
• Ohta A, Sitkovsky M. The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol 2009;9:501-6
   PubMed Web of Science ®Google Scholar
• McColl SR, St-Onge M, Dussault AA, Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J 2006;20:187-9
   PubMedGoogle Scholar
• Naganuma M, Wiznerowicz EB, Lappas CM, Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 2006;177:2765-9
   PubMed Web of Science ®Google Scholar
• Sevigny CP, Li L, Awad AS, Activation of adenosine A2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 2007;178:4240-9
   PubMed Web of Science ®Google Scholar
• Deaglio S, Dwyer KM, Gao W, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-65
   PubMed Web of Science ®Google Scholar
• Borsellino G, Kleinewietfeld M, Di Mitri D, Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007;110:1225-32
   PubMed Web of Science ®Google Scholar
• Himer L, Csoka B, Selmeczy Z, Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J 2010;24:2631-40
   PubMed Web of Science ®Google Scholar
• Ahmad A, Ahmad S, Glover L, Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci USA 2009;106:10684-9
   PubMed Web of Science ®Google Scholar
• Ernens I, Leonard F, Vausort M, Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem Biophys Res Commun 2010;392:351-6
   PubMed Web of Science ®Google Scholar
• Montesinos MC, Desai A, Cronstein BN. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res Ther 2006;8:R53
   PubMedGoogle Scholar
• Chan ES, Cronstein BN. Methotrexate–how does it really work? Nat Rev Rheumatol 2010;6:175-8
   PubMed Web of Science ®Google Scholar
• Varani K, Massara A, Vincenzi F, Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum 2009;60:2880-91
   PubMed Web of Science ®Google Scholar
• Sitkovsky MV, Lukashev D, Apasov S, Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004;22:657-82
   PubMed Web of Science ®Google Scholar
• Sitkovsky MV. T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 2009;30:102-8
   PubMed Web of Science ®Google Scholar
• Koizumi S, Odashima M, Otaka M, Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats. J Gastroenterol 2009;44:419-25
   PubMed Web of Science ®Google Scholar
• Polosa R, Blackburn MR. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 2009;30:528-35
   PubMed Web of Science ®Google Scholar
• Mohsenin A, Mi T, Xia Y, Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am J Physiol Lung Cell Mol Physiol 2007;293:753-61
   Google Scholar
• Wallace KL, Linden J. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood 2010;116:5010-20
   PubMed Web of Science ®Google Scholar
• Varani K, Caramori G, Vincenzi F, Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:398-406
   PubMed Web of Science ®Google Scholar
• Kong T, Westerman KA, Faigle M, HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006;20:2242-50
   PubMed Web of Science ®Google Scholar
• Yang M, Ma C, Liu S, HIF-dependent induction of adenosine receptor A2B skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol Cell Biol 2010;88:165-71
   PubMed Web of Science ®Google Scholar
• Gessi S, Fogli E, Sacchetto V, Adenosine modulates HIF-1alpha, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol 2010;30:90-7
   PubMed Web of Science ®Google Scholar
• Cohen MV, Yang X, Downey JM. A2B adenosine receptors can change their spots. Br J Pharmacol 2010;159:1595-7
   PubMed Web of Science ®Google Scholar
• Feoktistov I, Biaggioni I. Adenosine A2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 1995;96:1979-86
   PubMed Web of Science ®Google Scholar
• Hasko G, Pacher P, Vizi ES, Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 2005;26:511-16
   PubMed Web of Science ®Google Scholar
• Feng MG, Navar LG. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol 2010;299:F310-15
   PubMed Web of Science ®Google Scholar
• Rajagopal M, Pao AC. Adenosine activates A2B receptors and enhances chloride secretion in kidney inner medullary collecting duct cells. Hypertension 2010;55:1123-8
   PubMed Web of Science ®Google Scholar
• Wakeno M, Minamino T, Seguchi O, Long-term stimulation of adenosine A2B receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation 2006;114:1923-32
   PubMed Web of Science ®Google Scholar
• Philipp S, Yang XM, Cui L, Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2B receptor cascade. Cardiovasc Res 2006;70:308-14
   PubMed Web of Science ®Google Scholar
• Kuno A, Critz SD, Cui L, Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2B-dependent signaling during early reperfusion. J Mol Cell Cardiol 2007;43:262-71
   PubMed Web of Science ®Google Scholar
• Kuno A, Solenkova NV, Solodushko V, Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2B agonists by protein kinase C. Am J Physiol Heart Circ Physiol 2008;295:H1288-95
   PubMed Web of Science ®Google Scholar
• Methner C, Schmidt K, Cohen MV, Both A2A and A2B adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol 2010;299:H1262-4
   PubMed Web of Science ®Google Scholar
• Koda K, Salazar-Rodriguez M, Corti F, Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 2010;122:771-81
   PubMed Web of Science ®Google Scholar
• Yang D, Chen H, Koupenova M, A new role for the A2B adenosine receptor in regulating platelet function. J Thromb Haemost 2010;8:817-27
   PubMed Web of Science ®Google Scholar
• Strohmeier GR, Reppert SM, Lencer WI, The A2B adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 1995;270:2387-94
   PubMed Web of Science ®Google Scholar
• Ham M, Mizumori M, Watanabe C, Endogenous luminal surface adenosine signaling regulates duodenal bicarbonate secretion in rats. J Pharmacol Exp Ther 2010;335:607-13
   PubMed Web of Science ®Google Scholar
• Sitaraman SV, Merlin D, Wang L, Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 2001;107:861-9
   PubMed Web of Science ®Google Scholar
• Kolachala VL, Wang L, Obertone TS, Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA. J Biol Chem 2010;285:18184-90
   Google Scholar
• Kolachala VL, Vijay-Kumar M, Dalmasso G, A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 2008;135:861-70
   PubMed Web of Science ®Google Scholar
• Frick JS, MacManus CF, Scully M, Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 2009;182:4957-64
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Rivera-Nieves J, Colgan SP. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets 2009;13:1267-77
   PubMed Web of Science ®Google Scholar
• Hasko G, Csoka B, Nemeth ZH, A(2B) adenosine receptors in immunity and inflammation. Trends Immunol 2009;30:263-70
   PubMed Web of Science ®Google Scholar
• Ben Addi A, Lefort A, Hua X, Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A2B receptor. Eur J Immunol 2008;38:1610-20
   PubMed Web of Science ®Google Scholar
• Novitskiy SV, Ryzhov S, Zaynagetdinov R, Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 2008;112:1822-31
   PubMed Web of Science ®Google Scholar
• Feoktistov I, Polosa R, Volgate ST, Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 1998;19:148-53
   PubMed Web of Science ®Google Scholar
• Sun CX, Zhong H, Mohsenin A, Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 2006;116:2173-82
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang Y, Nguyen HG, The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006;116:1913-23
   PubMed Web of Science ®Google Scholar
• Schingnitz U, Hartmann K, Macmanus CF, Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 2010;184:5271-9
   PubMed Web of Science ®Google Scholar
• Allen-Gipson DS, Blackburn MR, Schneider DJ, Adenosine activation of A2B Receptor(s) is essential for stimulated epithelial ciliary motility and clearance. Am J Physiol Lung Cell Mol Physiol 2011;301:L171-80
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang Y, Yang M, Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A2. Cell Mol Immunol 2010;7:77-82
   PubMed Web of Science ®Google Scholar
• Baraldi PG, Borea PA. New potent and selective human adenosine A(3) receptor antagonists. Trends Pharmacol Sci 2000;21:456-9
   PubMed Web of Science ®Google Scholar
• Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007;26:3100-12
   PubMed Web of Science ®Google Scholar
• Jacobson KA. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 1998;19:184-91
   PubMed Web of Science ®Google Scholar
• Fedorova IM, Jacobson MA, Basile QA, Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol 2003;23:431-47
   PubMed Web of Science ®Google Scholar
• Ge ZD, Peart JN, Kreckler LM, Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 2006;319:1200-10
   PubMed Web of Science ®Google Scholar
• Black RG, Guo Y, Ge ZD, Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circ Res 2002;91:165-72
   PubMed Web of Science ®Google Scholar
• Funakoshi H, Chan TO, Good JC, Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation 2006;114:2240-50
   PubMed Web of Science ®Google Scholar
• Karjian P, Al-Rajaibi H, Hussain A, Activation of A3 adenosine receptors protects the ischemic reperfused myocardium via recruitment of PI3K-AKT-iNOS cell survival pathway. Circulation 2006;114:II_1204
   Web of Science ®Google Scholar
• Karjian P, Al-Rajaibi H, Hussain A, A3 adenosine receptor activation via 2-Cl-IBMECA protects the myocardium via recruitment of PI3K-AKT-iNOS intracellular signalling pathway during reperfusion. J Mol Cell Cardiol 2008;44:738
   Google Scholar
• Hussain A, Karjian P, Maddock H. The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection. Auton Autacoid Pharmacol 2009;29:97-104
   PubMedGoogle Scholar
• Zhou R, Chen F, Li Q, Stimulation of the adenosine A3 receptor reverses vascular hyporeactivity after hemorrhagic shock in rats. Acta Pharmacol Sin 2010;31:413-20
   PubMed Web of Science ®Google Scholar
• Gessi S, Varani K, Merighi S, A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 2002;61:415-24
   PubMed Web of Science ®Google Scholar
• Chen Y, Corriden R, Inoue Y, ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006;314:1792-5
   PubMed Web of Science ®Google Scholar
• Linden J. Cell biology. Purinergic chemotaxis. Science 2006;314:1689-90
   PubMed Web of Science ®Google Scholar
• Morschl E, Molina JG, Volmer JB, A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2008;39:697-705
   PubMed Web of Science ®Google Scholar
• Brown RA, Spina D, Page CP. Adenosine receptors and asthma. Br J Pharmacol 2008;153:S446-56
   PubMed Web of Science ®Google Scholar
• Gessi S, Merighi S, Varani K, The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 2008;117:123-40
   PubMed Web of Science ®Google Scholar
• Merighi S, Mirandola P, Varani K, A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 2003;100:31-48
   PubMed Web of Science ®Google Scholar
• Merighi S, Benini A, Mirandola P, A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 2005;280:19516-26
   PubMed Web of Science ®Google Scholar
• Kim H, Kang JW, Lee S, A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Anticancer Res 2010;30:2823-30
   PubMed Web of Science ®Google Scholar
• Gessi S, Merighi S, Varani K, Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype. J Cell Physiol 2007;211:826-36
   PubMed Web of Science ®Google Scholar
• Taliani S, La Motta C, Mugnaini L, Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation. J Med Chem 2010;53:3954-63
   PubMed Web of Science ®Google Scholar
• Varani K, Maniero S, Vincenzi F, A3 Receptors are overexpressed in Pleura from Mesothelioma patients and reduce cell growth via Akt/NF-kB pathway. Am J Respir Crit Care Med 2011;183:522-30
   PubMed Web of Science ®Google Scholar
• Fishman P, Bar-Yehuda S, Ohana G, An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. Oncogene 2004;23:2465-71
   PubMed Web of Science ®Google Scholar
• Merighi S, Benini A, Mirandola P, A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells. Neoplasia 2005;7:894-903
   PubMed Web of Science ®Google Scholar
• Merighi S, Benini A, Mirandola P, Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. Biochem Pharmacol 2006;72:19-31
   PubMed Web of Science ®Google Scholar
• Merighi S, Benini A, Mirandola P, Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells. Mol Pharmacol 2007;72:162-72
   PubMed Web of Science ®Google Scholar
• Merighi S, Benini A, Mirandola P, Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 2007;72:395-406
   PubMed Web of Science ®Google Scholar
• Merighi S, Simioni C, Gessi S, A2B and A3 adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia 2009;11:1064-73
   PubMed Web of Science ®Google Scholar
• Gessi S, Cattabriga E, Avitabile A, Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 2004;10:5895-901
   PubMed Web of Science ®Google Scholar
• Gessi S, Varani K, Merighi S, Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol Pharmacol 2004;65:711-19
   PubMed Web of Science ®Google Scholar
• Bar-Yehuda S, Stemmer SM, Madi L, The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol 2008;33:287-95
   PubMed Web of Science ®Google Scholar
• Jajoo S, Mukherjea D, Watabe K, Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia 2009;11:1132-45
   PubMed Web of Science ®Google Scholar
• Gessi S, Sacchetto V, Fogli E, Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors. Biochem Pharmacol 2010;79:1483-95
   PubMed Web of Science ®Google Scholar
• Fishman P, Bar-Yehuda S, Synowitz M, Adenosine receptors and cancer. Handb Exp Pharmacol 2009;193:399-41
   PubMedGoogle Scholar
• Gessi S, Merighi S, Sacchetto V, Adenosine receptors and cancer. Biochim Biophys Acta 2010;30:90-7
   Google Scholar
• Fishman P, Bar-Yehuda S, Madi L, The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther 2006;8:R33
   PubMed Web of Science ®Google Scholar
• Sajjadi FG, Takabayashi K, Foster AC, Inhibition of TNF-alpha expression by adenosine. Role of A3 receptors. J Immunol 1996;156:3435-42
   PubMed Web of Science ®Google Scholar
• Lee JY, Jhun BS, Oh YT, Activation of adenosine A3 receptor suppresses lipopolysaccaride-induced TNF-alpha production through inhibition of PI-3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells. Neurosci Lett 2006;396:1-6
   PubMed Web of Science ®Google Scholar
• Salvatore CA, Tilley SL, Latour AM, Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 2000;275:4429-34
   PubMed Web of Science ®Google Scholar
• Martin L, Pingle SC, Hallam DM, Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 2006;316:71-8
   PubMed Web of Science ®Google Scholar
• Kreckler LM, Wan TC, Ge ZD, Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 2006;317:172-80
   PubMed Web of Science ®Google Scholar
• Hasko G, Pacher P, Deitch EA, Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 2007;113:264-75
   PubMed Web of Science ®Google Scholar
• Madi L, Cohen S, Ochaion A, Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. J Rheumatol 2007;34:20-6
   PubMed Web of Science ®Google Scholar
• Lee HT, Kim M, Joo JD, A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Am J Physiol Regul Integr Comp Physiol 2006;291:R959-69
   PubMed Web of Science ®Google Scholar
• Inoue Y, Tanaka H, Sumi Y, A3 adenosine receptor inhibition improves the efficacy of hypertonic saline resuscitation. Shock 2010;35:178-83
   Web of Science ®Google Scholar
• Matot I, Weiniger CF, Zeira E, A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion. Crit Care 2006;10:R65
   PubMed Web of Science ®Google Scholar
• Yang H, Avila MY, Peterson-Yantorno K, The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure. Curr Eye Res 2005;30:747-54
   PubMed Web of Science ®Google Scholar
• Wang Z, Do CW, Avila MY, Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species. Exp Eye Res 2010;90:146-54
   PubMed Web of Science ®Google Scholar
• Zhang M, Budak MT, Lu W, Identification of the A3 adenosine receptor in rat retinal ganglion cells. Mol Vis 2006;12:937-48
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang M, Laties AM, Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. J Neurochem 2006;98:566-75
   PubMed Web of Science ®Google Scholar
• Zhang M, Hu H, Zhang X, The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells. Neurochem Int 2010;56:35-41
   PubMed Web of Science ®Google Scholar
• Hu H, Lu W, Zhang M, Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. Exp Eye Res 2010;91:425-32
   PubMed Web of Science ®Google Scholar
• Avni I, Garzozi HJ, Barequet IS, Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial. Ophthalmology 2010;117:1287-93
   PubMed Web of Science ®Google Scholar
• Varani K, Merighi S, Gessi S, [3H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. Mol Pharmacol 2000;57:968-75
   PubMed Web of Science ®Google Scholar
• Gessi S, Varani K, Merighi S, Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20. Mol Pharmacol 2005;67:2137-47
   PubMed Web of Science ®Google Scholar